论文信息 - Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron - 字舞流文

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron

K. Eschke | V. Corman | H. Prüss | R. Rose | L. Sander | V. Nölle | S. Reincke | A. Krumbholz | J. Kreye | H. Kornau | Elisa Sanchez-Sendin | Azza Abdelgawad | L. Jeworowski | T. Schwarz | M. Meyer | Peter Hombach | D. Schmitz | Sophie Merz | J. Trimpert | J. Adler | Marie L Schmidt | Stefan Edelburg | Sophia Halbe | S. Kattenbach | Uwe Janßen | Martin Meyer | L. M. Jeworowski | S. M. Reincke | Elisa Sánchez-Sendín